A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Search Results for " Everolimus "

media.product.imagealternatetextformat.details

Everolimus t-Butyldimethylsilyl Ether

N° de SZ CAT:SZ-E024008
Número CAS159351-68-5
Mol.F.C59H97NO14Si
Peso Molecular1072.5
Status de FaturaIn Stock

Nome Químico: 42-O-t-Butyldimethylsilyloxyethyl Rapamycin

Shipping Temperature: Ambient

HSN Code: 38229010

Country of Origin: India

Sorrisos: O=C(C([C@](O[C@]1([H])C[C@@H](/C(C)=C/C=C/C=C/[C@H]2C)OC)([C@@H](CC1)C)O)=O)N(CCCC3)[C@]3([H])C(O[C@](CC([C@@H](/C=C([C@H]([C@H](C([C@H](C)C2)=O)OC)O)\C)C)=O)([H])[C@H](C)C[C@H](CC[C@H]4OCCO[Si](C)(C)C(C)(C)C)C[C@H]4OC)=O

Everolimus t-Butyldimethylsilyl Ether is chemically 42-O-t-Butyldimethylsilyloxyethyl Rapamycin. Everolimus t-Butyldimethylsilyl Ether is supplied with detailed characterization data compliant with regulatory guideline. Everolimus t-Butyldimethylsilyl Ether can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Everolimus .

The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.

Disclaimer

SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.

SynZeal will update these details as per new development or finding in product specification without further noticed.